Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $869,880 | $862,169 | $860,857 | $460 |
| - Cash | $303,576 | $303,576 | $216,845 | $194,985 |
| + Debt | $243,627 | $243,627 | $227,298 | $247,411 |
| Enterprise Value | $809,931 | $802,220 | $871,310 | $52,886 |
| Revenue | $347,411 | $347,411 | $370,812 | – |
| % Growth | 0% | -6.3% | – | – |
| Gross Profit | $180,027 | $180,027 | $201,380 | – |
| % Margin | 51.8% | 51.8% | 54.3% | – |
| EBITDA | $69,266 | $69,266 | $41,377 | – |
| % Margin | 19.9% | 19.9% | 11.2% | – |
| Net Income | $33,593 | $33,593 | $15,311 | – |
| % Margin | 9.7% | 9.7% | 4.1% | – |
| EPS Diluted | 0.057 | 0.057 | 0.026 | – |
| % Growth | 0% | 119.2% | – | – |
| Operating Cash Flow | $92,157 | $92,157 | $91,518 | – |
| Capital Expenditures | -$4,974 | -$4,974 | -$16,212 | – |
| Free Cash Flow | $87,182 | $87,182 | $75,306 | – |